New York-Presbyterian Hospital
Over the next year or so, the investigators plan to sequence the genomes of 3,000 patients with cancer, heart disease, diabetes, or neurological disorders.
Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing
Weill Cornell Medicine, New York-Presbyterian Hospital, and the New York Genome Center will join Illumina to sequence the genomes of thousands of patients.
After three years of work, the EXaCT-1 exome cancer test has become part of clinical cancer care at NewYork-Presbyterian, but developers have higher ambitions.
Biotia Aims to Cut Hospital-Acquired Infections by Monitoring Microbiome of Hospital Environment
The company hopes to raise funding this summer and has been conducting pilots with NewYork-Presbyterian Hospital and Memorial Sloan Kettering Cancer Center.
The partners aim to identify master regulators in the molecular networks of GIST patients that can serve as drug targets for existing treatments.